UBS(Lux)E.F.-S.Health Tr.(USD)Q CHF H
LU2402148733
UBS(Lux)E.F.-S.Health Tr.(USD)Q CHF H/ LU2402148733 /
NAV30/08/2024 |
Chg.+0.2800 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
110.9100EUR |
+0.25% |
reinvestment |
Equity
Worldwide
|
UBS Fund M. (LU) ▶ |
Stratégie d'investissement
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
The portfolio manager has discretion to construct the portfolio and is not bound by the benchmark in terms of equities and weightings. The investment fund is actively managed relative to the benchmark MSCI World Health Care (net div. reinv.). The investment fund uses the benchmark MSCI World Health Care (net div. reinv.) for portfolio composition, performance comparison and risk management.
Objectif d'investissement
The actively managed investment fund invests worldwide primarily in equities of companies related to the healthcare sector. This sub-fund promotes environmental and/or social features but does not pursue a sustainable investment objective. Based on thorough analyses by our investment specialists, the fund manager combines carefully selected stocks of different companies from different countries and different segments of the sector with the objective of taking advantage of interesting opportunities for returns while keeping risks under control. UBS Asset Management classifies this investment fund as a Sustainability Focus Fund, which promotes environmental and/or social characteristics.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Health / Pharma |
Benchmark: |
MSCI World Health Care (net div. reinv.) |
Début de l'exercice: |
01/12 |
Dernière distribution: |
- |
Banque dépositaire: |
UBS Europe SE, Luxembourg Branch |
Domicile: |
Luxembourg |
Permission de distribution: |
Austria, Germany, Switzerland, Czech Republic |
Gestionnaire du fonds: |
Matthew Konosky, Scott Wilkin, Caroline Wallace |
Actif net: |
226.78 Mio.
USD
|
Date de lancement: |
24/11/2021 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
0.77% |
Investissement minimum: |
- EUR |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
UBS Fund M. (LU) |
Adresse: |
33A avenue J.F. Kennedy, 1855, Luxembourg |
Pays: |
Luxembourg |
Internet: |
www.ubs.com
|
Actifs
Stocks |
|
98.68% |
Cash |
|
1.24% |
Autres |
|
0.08% |
Pays
United States of America |
|
58.79% |
Switzerland |
|
14.32% |
United Kingdom |
|
9.32% |
Netherlands |
|
6.00% |
Japan |
|
4.62% |
Denmark |
|
2.14% |
China |
|
1.51% |
Cash |
|
1.24% |
Germany |
|
0.82% |
Virgin Islands (British) |
|
0.66% |
Ireland |
|
0.50% |
Autres |
|
0.08% |
Branches
Pharma/Biotechnology |
|
50.82% |
Healthcare services |
|
27.90% |
Healthcare appliances |
|
16.53% |
grooming products |
|
1.56% |
Cash |
|
1.24% |
Gesundheitswesen/ Informationstechnologie |
|
1.09% |
Parma, wholesale |
|
0.79% |
Autres |
|
0.07% |